Evidence map›Paper›PMID 41318757›Full record

ArticleScientific reports2025

Complement and diverse enrichment of antibodies in intraluminal thrombi from abdominal aortic aneurysms may contribute to increased inflammation.

Vibeke Videm, Animesh Sharma, Torbjørn Dahl

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Vibeke VidemDepartment of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway. Vibeke.Videm@ntnu.no.
Animesh SharmaDepartment of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.
Torbjørn DahlDepartment of Surgery, St. Olavs University Hospital, Trondheim, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Abdominal aortic aneurysms (AAA) often contain an intraluminal thrombus (ILT) which may contribute to aneurysm growth and rupture, but the mechanisms are not well understood. We hypothesized that complement and antibodies play a central role in the immune reactions within ILT from AAA. We quantified pre-specified proteins from complement and other defense systems, including coagulation, fibrinolysis, neutrophils, relevant proteinases and inhibitors, as well as immunoglobulins in ILT (n = 7), using fresh thrombi for comparison (n = 7). Protein analysis was performed using liquid chromatography in tandem with mass spectrometry, permitting simultaneous protein detection with comparable quantitative results, and antibody diversity characterization. The results indicated complement activation (classical and lectin pathways), coagulation (contact pathway), and degranulation including proteinase release from neutrophils in the ILT, with protein enrichment compared to fresh thrombi. Inhibitors of these systems were also present. In the ILT, 151 different immunoglobulin heavy chain and 144 different light chain variable regions were detected. Corresponding numbers in the controls were 25 and 26. Immunohistochemistry confirmed terminal complement activation and substantial presence of IgG in the ILT, which also contained IgM and IgA. These results are suggestive of a complex immunological process with activation of many defense systems, and antibody enrichment in the ILT.

Indexed as

AntibodiesAortic Aneurysm, AbdominalComplement System ProteinsInflammationThrombosisAgedAged, 80 and overComplement ActivationFemaleHumansMaleMiddle AgedNeutrophilsAntibodiesComplement System ProteinsAbdominal aortic aneurysmAntibody formationImmune activationIntraluminal thrombusProteomics

Identifiers

PMID41318757
PMCPMC12770350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.